{"pmid":32275124,"title":"Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm.","text":["Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm.","The pandemic caused by severe acute respiratory syndrome coronavirus 2 heavily involves all those working in a laboratory. Samples from known infected patients or donors who are considered healthy can arrive, and a colleague might be asymptomatic but able to transmit the virus. Working in a clinical laboratory is posing several safety challenges. Few years ago, International Society for Advancement of Cytometry published guidelines to safely analyze and sort human samples that were revised in these days. We describe the procedures that we have been following since the first patient appeared in Italy, which have only slightly modified our standard one, being all human samples associated with risks. (c) 2020 International Society for Advancement of Cytometry.","Cytometry A","Cossarizza, Andrea","Gibellini, Lara","De Biasi, Sara","Lo Tartaro, Domenico","Mattioli, Marco","Paolini, Annamaria","Fidanza, Lucia","Bellinazzi, Caterina","Borella, Rebecca","Castaniere, Ivana","Meschiari, Marianna","Sita, Marco","Manco, Gianrocco","Clini, Enrico","Gelmini, Roberta","Girardis, Massimo","Guaraldi, Giovanni","Mussini, Cristina","32275124"],"abstract":["The pandemic caused by severe acute respiratory syndrome coronavirus 2 heavily involves all those working in a laboratory. Samples from known infected patients or donors who are considered healthy can arrive, and a colleague might be asymptomatic but able to transmit the virus. Working in a clinical laboratory is posing several safety challenges. Few years ago, International Society for Advancement of Cytometry published guidelines to safely analyze and sort human samples that were revised in these days. We describe the procedures that we have been following since the first patient appeared in Italy, which have only slightly modified our standard one, being all human samples associated with risks. (c) 2020 International Society for Advancement of Cytometry."],"journal":"Cytometry A","authors":["Cossarizza, Andrea","Gibellini, Lara","De Biasi, Sara","Lo Tartaro, Domenico","Mattioli, Marco","Paolini, Annamaria","Fidanza, Lucia","Bellinazzi, Caterina","Borella, Rebecca","Castaniere, Ivana","Meschiari, Marianna","Sita, Marco","Manco, Gianrocco","Clini, Enrico","Gelmini, Roberta","Girardis, Massimo","Guaraldi, Giovanni","Mussini, Cristina"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275124","week":"202015|Apr 06 - Apr 12","doi":"10.1002/cyto.a.24009","keywords":["Covid-19","SARS-CoV-2","biosafety","coronavirus","cytokines","cytometry"],"source":"PubMed","locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1663712077962805248,"score":7.9164424,"similar":[{"pmid":32187818,"title":"The Cholera Epidemics in Hamburg and What to Learn for COVID-19 (SARS-CoV-2).","text":["The Cholera Epidemics in Hamburg and What to Learn for COVID-19 (SARS-CoV-2).","(c) 2020 International Society for Advancement of Cytometry.","Cytometry A","Tarnok, Attila","32187818"],"abstract":["(c) 2020 International Society for Advancement of Cytometry."],"journal":"Cytometry A","authors":["Tarnok, Attila"],"date":"2020-03-19T11:00:00Z","year":2020,"_id":"32187818","week":"202012|Mar 16 - Mar 22","doi":"10.1002/cyto.a.23999","keywords":["COVID-19","Cholera","SARS-CoV-2"],"source":"PubMed","locations":["Hamburg"],"countries":["Germany"],"countries_codes":["DEU|Germany"],"topics":["Prevention"],"weight":1,"_version_":1663352133792038913,"score":245.17519},{"pmid":32116147,"title":"Coronavirus disinfection in histopathology.","text":["Coronavirus disinfection in histopathology.","The 2019 Coronavirus epidemic, provisionally called 2019-nCoV, was first identified in Wuhan, China, in persons exposed to a seafood or wet market. There is an international push to contain the virus and prevent its spread. It is feasible that potentially infectious samples may be received in histopathology laboratories for diagnosis. This technical note presents disinfection procedures and histotechnology processes that should alleviate the risk of infection to laboratory staff. Using data obtained from similar coronaviruses, e.g. severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), experts are confident that 70% ethanol and 0.1% sodium hypochlorite should inactivate the virus. Formalin fixation and heating samples to 56oC, as used in routine tissue processing, were found to inactivate several coronaviruses and it is believed that 2019-nCoV would be similarly affected.","J Histotechnol","Henwood, Anthony F","32116147"],"abstract":["The 2019 Coronavirus epidemic, provisionally called 2019-nCoV, was first identified in Wuhan, China, in persons exposed to a seafood or wet market. There is an international push to contain the virus and prevent its spread. It is feasible that potentially infectious samples may be received in histopathology laboratories for diagnosis. This technical note presents disinfection procedures and histotechnology processes that should alleviate the risk of infection to laboratory staff. Using data obtained from similar coronaviruses, e.g. severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), experts are confident that 70% ethanol and 0.1% sodium hypochlorite should inactivate the virus. Formalin fixation and heating samples to 56oC, as used in routine tissue processing, were found to inactivate several coronaviruses and it is believed that 2019-nCoV would be similarly affected."],"journal":"J Histotechnol","authors":["Henwood, Anthony F"],"date":"2020-03-03T11:00:00Z","year":2020,"_id":"32116147","week":"202010|Mar 02 - Mar 08","doi":"10.1080/01478885.2020.1734718","keywords":["Coronavirus","SARS-CoV-2","biosafety","disinfection","histopathology laboratory","histotechnology"],"source":"PubMed","locations":["Formalin","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"e_drugs":["Ethanol","Sodium Hypochlorite","Formaldehyde"],"_version_":1663352134344638465,"score":164.65424},{"pmid":32125132,"title":"[Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of COVID-19 (Trial version)].","text":["[Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of COVID-19 (Trial version)].","The outbreak of coronavirus disease 2019 (COVID-19) has become a public health emergency of major international concern. Given the systemic immunosuppressive state caused by malignancy and anticancer treatments, patients with advanced lung cancer may be at a higher risk of COVID-19 infection. During epidemic of COVID-19, a guideline for the optimal management of patients with advanced lung cancer urgently needs to be proposed to distinguish the symptoms of COVID-19 and the side effects of antitumor drugs. This network questionnaire survey was conducted on the lung cancer group of the Chinese Thoracic Society, Chinese Medical Association; the lung cancer group of the Chinese Society of Clinical Oncology Youth Committee; and the Chinese Respiratory Oncology Collaboration. 321 valid questionnaires were received. Based on the guidelines on lung cancer and the results of the questionnaires, a consensus was reached. During the epidemic of COVID-19, We recommended that patients with advanced NSCLC should be treated as outpatients as possible at the nearest medical center; Patients who need to be hospitalized for antitumor treatment should be excluded from COVID-19 infection; More intensive attention should be paid to identification of COVID-19-related symptoms and adverse reactions caused by the malignancy or antitumor treatments. Stronger personal protection should be made for advanced NSCLC patients; An intentional postponing of antitumor treatment should be considered according to patient performance status. Treatment strategies should be made according to different types of advanced NSCLC patients and efficacy and toxicity of drugs.","Zhonghua Jie He He Hu Xi Za Zhi","32125132"],"abstract":["The outbreak of coronavirus disease 2019 (COVID-19) has become a public health emergency of major international concern. Given the systemic immunosuppressive state caused by malignancy and anticancer treatments, patients with advanced lung cancer may be at a higher risk of COVID-19 infection. During epidemic of COVID-19, a guideline for the optimal management of patients with advanced lung cancer urgently needs to be proposed to distinguish the symptoms of COVID-19 and the side effects of antitumor drugs. This network questionnaire survey was conducted on the lung cancer group of the Chinese Thoracic Society, Chinese Medical Association; the lung cancer group of the Chinese Society of Clinical Oncology Youth Committee; and the Chinese Respiratory Oncology Collaboration. 321 valid questionnaires were received. Based on the guidelines on lung cancer and the results of the questionnaires, a consensus was reached. During the epidemic of COVID-19, We recommended that patients with advanced NSCLC should be treated as outpatients as possible at the nearest medical center; Patients who need to be hospitalized for antitumor treatment should be excluded from COVID-19 infection; More intensive attention should be paid to identification of COVID-19-related symptoms and adverse reactions caused by the malignancy or antitumor treatments. Stronger personal protection should be made for advanced NSCLC patients; An intentional postponing of antitumor treatment should be considered according to patient performance status. Treatment strategies should be made according to different types of advanced NSCLC patients and efficacy and toxicity of drugs."],"journal":"Zhonghua Jie He He Hu Xi Za Zhi","date":"2020-03-04T11:00:00Z","year":2020,"_id":"32125132","week":"202010|Mar 02 - Mar 08","doi":"10.3760/cma.j.cn112147-20200221-00138","keywords":["Advanced non-small cell lung cancer","COVID-19","Management"],"source":"PubMed","locations":["optimal"],"topics":["Treatment","Diagnosis","Prevention"],"weight":1,"_version_":1663352134282772480,"score":158.02432},{"pmid":32243296,"title":"The Essential Role of Patient Blood Management in a Pandemic: A Call for Action.","text":["The Essential Role of Patient Blood Management in a Pandemic: A Call for Action.","The World Health Organization (WHO) has declared Coronavirus Disease 2019 (COVID-19), the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a pandemic. Global health care now faces unprecedented challenges with widespread and rapid human-to-human transmission of SARS-CoV-2 and high morbidity and mortality with COVID-19 worldwide. Across the world, the medical care is hampered by a critical shortage of not only hand sanitizers, personal protective equipment, ventilators and hospital beds, but also impediments to the blood supply. Blood donation centers in many areas around the globe have mostly closed. Donors, practicing social distancing, some either with illness or undergoing self-quarantine, are quickly diminishing. Drastic public health initiatives have focused on containment and \"flattening the curve\" while invaluable resources are being depleted. In some countries, the point is reached at which demand for such resources, including donor blood outstrips supply. Questions as to the safety of blood persist. Although it does not appear very likely that the virus can be transmitted through allogeneic blood transfusion, this still remains to be fully determined. As options dwindle, we must enact regional and national shortage plans worldwide, and more vitally disseminate the knowledge of and immediately implement Patient Blood Management (PBM). PBM is an evidence-based bundle of care to optimize medical and surgical patient outcomes by clinically managing and preserving a patient's own blood. This multinational and diverse group of authors issue this \"Call to Action\" underscoring \"The Essential Role of Patient Blood Management in the Management of Pandemics\" and urging all stakeholders and providers to implement the practical and common-sense principles of PBM and its multi-professional and multimodality approaches.","Anesth Analg","Shander, Aryeh","Goobie, Susan Marie","Warne, Matthew A","Aapro, Matti","Bisbe, Elvira","Perez-Calatayud, Angel A","Callum, Jeannie","Cushing, Melissa M","Dyer, Wayne B","Erhard, Jochen","Faraoni, David","Farmer, Shannon","Fedorova, Tatyana","Frank, Steven M","Froessler, Bernd","Gombotz, Hans","Gross, Irwin","Guinn, Nicole R","Haas, Thorsten","Hamdorf, Jeffrey","Isbister, James P","Javidroozi, Mazyar","Ji, Hongwen","Kim, Young-Woo","Kor, Daryl J","Kurz, Johann","Lasocki, Sigismond","Leahy, Michael F","Lee, Cheuk-Kwong","Lee, Jeong Jae","Louw, Vernon","Meier, Jens","Mezzacasa, Anna","Munoz, Manuel","Ozawa, Sherri","Pavesi, Marco","Shander, Nina","Spahn, Donat R","Spiess, Bruce D","Thomson, Jackie","Trentino, Kevin","Zenger, Christoph","Hofmann, Axel","32243296"],"abstract":["The World Health Organization (WHO) has declared Coronavirus Disease 2019 (COVID-19), the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a pandemic. Global health care now faces unprecedented challenges with widespread and rapid human-to-human transmission of SARS-CoV-2 and high morbidity and mortality with COVID-19 worldwide. Across the world, the medical care is hampered by a critical shortage of not only hand sanitizers, personal protective equipment, ventilators and hospital beds, but also impediments to the blood supply. Blood donation centers in many areas around the globe have mostly closed. Donors, practicing social distancing, some either with illness or undergoing self-quarantine, are quickly diminishing. Drastic public health initiatives have focused on containment and \"flattening the curve\" while invaluable resources are being depleted. In some countries, the point is reached at which demand for such resources, including donor blood outstrips supply. Questions as to the safety of blood persist. Although it does not appear very likely that the virus can be transmitted through allogeneic blood transfusion, this still remains to be fully determined. As options dwindle, we must enact regional and national shortage plans worldwide, and more vitally disseminate the knowledge of and immediately implement Patient Blood Management (PBM). PBM is an evidence-based bundle of care to optimize medical and surgical patient outcomes by clinically managing and preserving a patient's own blood. This multinational and diverse group of authors issue this \"Call to Action\" underscoring \"The Essential Role of Patient Blood Management in the Management of Pandemics\" and urging all stakeholders and providers to implement the practical and common-sense principles of PBM and its multi-professional and multimodality approaches."],"journal":"Anesth Analg","authors":["Shander, Aryeh","Goobie, Susan Marie","Warne, Matthew A","Aapro, Matti","Bisbe, Elvira","Perez-Calatayud, Angel A","Callum, Jeannie","Cushing, Melissa M","Dyer, Wayne B","Erhard, Jochen","Faraoni, David","Farmer, Shannon","Fedorova, Tatyana","Frank, Steven M","Froessler, Bernd","Gombotz, Hans","Gross, Irwin","Guinn, Nicole R","Haas, Thorsten","Hamdorf, Jeffrey","Isbister, James P","Javidroozi, Mazyar","Ji, Hongwen","Kim, Young-Woo","Kor, Daryl J","Kurz, Johann","Lasocki, Sigismond","Leahy, Michael F","Lee, Cheuk-Kwong","Lee, Jeong Jae","Louw, Vernon","Meier, Jens","Mezzacasa, Anna","Munoz, Manuel","Ozawa, Sherri","Pavesi, Marco","Shander, Nina","Spahn, Donat R","Spiess, Bruce D","Thomson, Jackie","Trentino, Kevin","Zenger, Christoph","Hofmann, Axel"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243296","week":"202014|Mar 30 - Apr 05","doi":"10.1213/ANE.0000000000004844","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352135774896129,"score":145.16711},{"pmid":32243255,"title":"Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations.","text":["Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations.","Because of high rates of 2019 novel coronavirus disease in Wuhan, China, Wuhan Blood Center began screening for severe acute respiratory syndrome coronavirus 2 RNA on January 25, 2020. We screened donations in real-time and retrospectively and found plasma samples positive for viral RNA from 4 asymptomatic donors.","Emerg Infect Dis","Chang, Le","Zhao, Lei","Gong, Huafei","Wang, Lunan","Wang, Lan","32243255"],"abstract":["Because of high rates of 2019 novel coronavirus disease in Wuhan, China, Wuhan Blood Center began screening for severe acute respiratory syndrome coronavirus 2 RNA on January 25, 2020. We screened donations in real-time and retrospectively and found plasma samples positive for viral RNA from 4 asymptomatic donors."],"journal":"Emerg Infect Dis","authors":["Chang, Le","Zhao, Lei","Gong, Huafei","Wang, Lunan","Wang, Lan"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243255","week":"202014|Mar 30 - Apr 05","doi":"10.3201/eid2607.200839","keywords":["2019 novel coronavirus disease","COVID-19","China","SARS","SARS-CoV-2","blood donors","coronavirus","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1663352135760216064,"score":142.80154}]}